Article
Elevated plasma dimethylglycine is a risk marker of mortality in patients with coronary heart disease.
European journal of preventive cardiology - 1 Jun 2015
Svingen Gard F T, Schartum-Hansen Hall, Ueland Per M, Pedersen Eva R, Seifert Reinhard, Ebbing Marta, Bønaa Kaare H, Mellgren Gunnar, Nilsen Dennis W T, Nordrehaug Jan E, Øyen Jannike, Nygård Ottar
Abstract excerpt
AIM: To investigate whether plasma dimethylglycine was associated with and improved risk prediction of mortality among patients with coronary heart disease (CHD). METHODS: By Cox modelling, we explored the association between plasma dimethylglycine and mortality in two independent cohorts of pati...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
